- Report
- January 2023
- 40 Pages
United Kingdom
From €1339EUR$1,500USD£1,169GBP
- Report
- January 2023
- 40 Pages
United States
From €1339EUR$1,500USD£1,169GBP
- Report
- June 2025
- 108 Pages
United States
From €2227EUR$2,495USD£1,944GBP
- Report
- March 2024
- 132 Pages
Global
From €848EUR$950USD£740GBP
- Report
- March 2024
- 132 Pages
Global
From €848EUR$950USD£740GBP
- Book
- February 2023
Africa
- Book
- September 2021
- 275 Pages
South Africa

The Botanical Drug market is a subset of the Pharmaceutical industry, focusing on the development and commercialization of drugs derived from plants. Botanical drugs are typically derived from natural sources, such as herbs, roots, and other plant-based materials. These drugs are often used to treat a variety of conditions, including chronic pain, inflammation, and neurological disorders. Botanical drugs are typically administered orally, and may also be used in combination with other drugs.
The Botanical Drug market is highly regulated, with stringent safety and efficacy standards in place to ensure the safety of patients. Additionally, the market is subject to a variety of government regulations, including those related to the manufacturing and distribution of botanical drugs.
Some companies in the Botanical Drug market include PhytoCeutica, Inc., PhytoTech Therapeutics, and PhytoHealth Corporation. Show Less Read more